Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 296,426 | 292,898 | 306,763 | 320,846 | 299,283 |
| Receivables | 207,066 | 200,752 | 202,657 | 211,949 | 213,534 |
| Inventories | 336,206 | 360,527 | 365,141 | 359,614 | 382,105 |
| TOTAL | $899,682 | $913,160 | $934,975 | $1,005,868 | $955,902 |
| Non-Current Assets | |||||
| PPE Net | 292,476 | 286,865 | 284,052 | 286,107 | 300,478 |
| Intangibles | 1,034,458 | 1,057,933 | 1,060,012 | 1,070,881 | 1,103,999 |
| Other Non-Current Assets | 215,540 | 204,136 | 171,909 | 168,414 | 164,845 |
| TOTAL | $1,542,474 | $1,548,934 | $1,515,973 | $1,525,402 | $1,569,322 |
| Total Assets | $2,442,156 | $2,462,094 | $2,450,948 | $2,531,270 | $2,525,224 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 61,691 | 46,010 | 66,999 | 62,990 | 69,242 |
| Accrued Expenses | 48,269 | 35,805 | 59,423 | 45,933 | 49,300 |
| Other current liabilities | 134,023 | 145,643 | 148,133 | 139,235 | 149,970 |
| TOTAL | $548,318 | $531,407 | $578,113 | $253,233 | $273,946 |
| Non-Current Liabilities | |||||
| Long Term Debt | 920,393 | 920,833 | 921,230 | 1,219,762 | 1,219,523 |
| Other Non-Current Liabilities | 66,071 | 68,066 | 68,194 | 89,964 | 90,011 |
| TOTAL | $1,044,665 | $1,048,387 | $1,051,999 | $1,371,177 | $1,372,427 |
| Total Liabilities | $1,592,983 | $1,579,794 | $1,630,112 | $1,624,410 | $1,646,373 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,810 | 48,177 | 48,037 | 50,237 | 50,224 |
| Common Shares | 467 | 482 | 482 | 502 | 504 |
| Retained earnings | 336,323 | 356,046 | 352,174 | 392,230 | 368,536 |
| Other shareholders' equity | -40,531 | -36,242 | -55,084 | -55,501 | -34,564 |
| TOTAL | $849,173 | $882,300 | $820,836 | $906,860 | $878,851 |
| Total Liabilities And Equity | $2,442,156 | $2,462,094 | $2,450,948 | $2,531,270 | $2,525,224 |